Показано 0 из 0
Дата |
---|
20:56 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
7.40
|
7.42
|
7.38
|
7.36
|
7.48
|
7.415
|
|
|
182 777.54
|
566.00
|
3.02
|
9.39
|
7.71
|
7.45
|
7.715
|
7.49
|
|
|
638 079.27
|
1 563.00
|
3.08
|
9.39
|
7.97
|
7.63
|
8.07
|
7.70
|
|
|
786 939.76
|
1 782.00
|
7.57
|
8.24
|
8.01
|
7.86
|
8.11
|
7.89
|
|
|
802 922.59
|
1 570.00
|
7.19
|
8.31
|
7.76
|
7.46
|
7.77
|
7.77
|
|
|
983 999.30
|
1 335.00
|
7.15
|
8.87
|
7.47
|
7.46
|
7.835
|
7.65
|
|
|
581 096.83
|
1 494.00
|
2.96
|
9.39
|
7.44
|
7.34
|
7.50
|
7.40
|
|
|
577 824.84
|
1 000.00
|
7.30
|
9.39
|
7.31
|
7.31
|
7.93
|
7.50
|
|
|
913 397.58
|
1 861.00
|
2.89
|
9.39
|
7.13
|
6.96
|
7.28
|
7.22
|
|
|
828 758.72
|
1 600.00
|
2.83
|
9.39
|
7.03
|
6.87
|
7.23
|
7.08
|
|
|
824 743.21
|
1 687.00
|
Aura Biosciences is leveraging a novel targeted oncology platform to develop a potential new standard of care across multiple cancer indications, with an initial focus on ocular and urologic oncology.